Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Clinical trial NCT03485209 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03485209
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Exocrine Pancreatic Cancer Carcinoma, Squamous Cell of Head and Neck

Start date: 2018-06-25
Primary completion: 2026-03-20
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.